Kevin Rist, MD
Clinical Cardiac Electrophysiology · Wausau, WINPI 1497734750
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,509 of the $15,650 with a category attached, or 67.1%. Atricure, Inc. accounts for 60.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $8,050 and has fallen 90.8% since, to $739 in 2025.
Across 93 payments — averaging $168.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$9K
- Abbott$4K
- Cardiofocus, Inc.$1K
- Medtronic$670
- Boston Scientific$166
- Abiomed$89
- plus $578 from 9 others
Across 68 payments — averaging $2730.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$177K
- Atricure, Inc.$8K
What the payments were for
- Travel & lodging$10,50967%
- Food & beverage$5,14233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 22 | $9,433 |
| Abbott | 39 | $3,645 |
| Cardiofocus, Inc. | 9 | $1,069 |
| Medtronic(2 entities) | 9 | $670 |
| Boston Scientific | 4 | $166 |
| Abiomed | 1 | $89 |
| Siemens Medical Solutions USA, Inc. | 1 | $87 |
| Cvrx, Inc. | 1 | $84 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $78 |
| Johnson & Johnson | 1 | $77 |
| Merck | 1 | $66 |
| Pfizer | 1 | $64 |
| Inspire Medical Systems, Inc. | 1 | $63 |
| Biotronik Inc. | 1 | $39 |
| Heartflow, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY ABLATION SYSTEM$7,415
- ISOLATOR SURGICAL ABLATION SYSTEM$7,268
- AVEIR$1,622
- ATRICURE ATRICLIP LAA EXCLUSION$599
- EPI-SENSE GUIDED COAGULATION SYS$324
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$233
- CARDIOMEMS$232
- HeartLight System$158
- ENSITE$139
- Ensite Cardiac Mapping System$128
- ATRICURE SYNERGY ABLATION SYSTEM$119
- NA$118
- Accent Pacemaker$114
- Confirm Rx$106
How this compares
$15,650 in reported general payments places this provider in the 55th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
See all clinical cardiac electrophysiology providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 323 | $299,463 |
| XareltoRivaroxaban | 82 | $88,606 |
| MultaqDronedarone Hcl | 76 | $66,351 |
| EntrestoSacubitril/Valsartan | 27 | $33,936 |
| JardianceEmpagliflozin | 41 | $33,130 |
| CorlanorIvabradine Hcl | 18 | $13,069 |
| Metoprolol Succinate | 447 | $7,295 |
| Flecainide Acetate | 125 | $5,633 |
| Amiodarone Hcl | 236 | $5,404 |
| Propafenone Hcl | 122 | $4,381 |
| Dofetilide | 31 | $3,319 |
| Mexiletine Hcl | 32 | $2,605 |
| SotalolSotalol Hcl | 103 | $2,307 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $2,302 |
| Potassium Chloride | 63 | $1,696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $299,463323 claims |
| Johnson & JohnsonXarelto | $77 | $88,60682 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
Other clinical cardiac electrophysiology in Wausau
- Danylo ZorinWausau$22K
- Andrew MykytseyWausau$13K
- Ronnie OrtizWausau$5K
- Imran NiaziMilwaukee$1M
- Miguel LealMadison$202K
- Jodi ZilinskiMilwaukee$173K
- Sanjay DeshpandeBeloit$133K
- Divya KorpuEau Claire$94K
- Marcie BergerMilwaukee$67K
- Mohammad MortadaMilwaukee$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.